Welcome to LookChem.com Sign In|Join Free

CAS

  • or

170565-55-6

Post Buying Request

170565-55-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

170565-55-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 170565-55-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,0,5,6 and 5 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 170565-55:
(8*1)+(7*7)+(6*0)+(5*5)+(4*6)+(3*5)+(2*5)+(1*5)=136
136 % 10 = 6
So 170565-55-6 is a valid CAS Registry Number.

170565-55-6Relevant articles and documents

Catalytic enantioselective mannich-type reaction with β-phenyl sulfonyl acetonitrile

Gonzalez, Pedro B.,Lopez, Rosa,Palomo, Claudio

supporting information; experimental part, p. 3920 - 3922 (2010/08/06)

Figure presented The organocatalytic addition of β-phenyl sulfonyl acetonitrile 1 to either N-Boc-protected α-amido sulfones or imines allowed the synthesis of enantioenriched α-unsubstituted β-amino nitriles through a Mannich-type reaction.

Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations formed therefrom

-

, (2008/06/13)

The present invention relates to spiroimidazolidine derivatives of the formula I in which E, V, W, X, R1and R2have the meanings indicated in the claims. The compounds of the formula I are valuable pharmaceutical active compounds which are suitable, for example, for the therapy and prophylaxis of inflammatory disorders, such as, for example, rheumatoid arthritis, or allergic disorders. The compounds of the formula I are also inhibitors of the adhesion and migration of leukocytes and/or antagonists of the adhesion receptor VLA-4 belonging to the integrins group. They are generally suitable for the therapy and prophylaxis of illnesses which are caused by an undesired extent of leukocyte adhesion and/or leukocyte migration or are associated therewith or in which cell-cell or cell-matrix interactions which are based on interactions of VLA-4 receptors with their ligands play a part. The invention also relates to processes for the preparation of the compounds of the formula I, pharmaceutical preparations which contain compounds of the formula I, and methods for treating these disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 170565-55-6